EUVIMEDEUVIMED entdecken
Crossref

Red Blood Cell Membrane-Camouflaged Nanoparticles for Synergistic Sonodynamic Therapy and TGF-β Inhibition to Reprogram Immunosuppressive Tumor Microenvironment

Zhipeng Liao, Haiqin Liao, Yi Luo, Sijie Chen, Mingyu Chen, Jiarong He, Yan Xu, Long Wang iD, Chengcheng Niu iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c07008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Zhipeng Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Transforming Growth Factor beta, Nanoparticles, Erythrocyte Membrane. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Science and Technology Program of Hunan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is highly metastatic and associated with a poor prognosis due to the lack of effective therapies. Current strategies focus on targeting the tumor microenvironment (TME), including immune checkpoint blockade (ICB) and transforming growth factor-β (TGF-β) pathway inhibition. Additionally, sonodynamic therapy (SDT) combined with ICB or immune modulators has demonstrated promising antitumor effects. We developed a red blood cell membrane-camouflaged nanoparticle (SB-IR-PLGA@RM) coencapsulating the sonosensitizer IR780 and the TGF-β signaling inhibitor SB431542. This biomimetic platform demonstrated enhanced tumor-targeted delivery via membrane coating technology. Under ultrasound irradiation, IR780-mediated SDT induced immunogenic cell death (ICD), promoting dendritic cell maturation and cytotoxic T lymphocyte infiltration. Concurrently, SB431542 effectively suppressed TGF-β signaling, leading to reprogramming of tumor-associated macrophages (TAMs) and neutrophils (TANs) into antitumor phenotypes, inhibition of cancer-associated fibroblasts activation (CAFs), and attenuation of epithelial-to-mesenchymal transition (EMT). This study demonstrated that SB-IR-PLGA@RM nanoparticles synergized SDT-induced ICD with TGF-β inhibition to remodel the immunosuppressive TME and amplify antitumor immunity. The integration with anti-PD-L1 (αPD-L1) provides a potent strategy against both primary and metastatic TNBC, highlighting the potential of TME-focused nanotherapeutics to overcome the limitations of conventional therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentTransforming Growth Factor betaNanoparticlesErythrocyte MembraneTriple Negative Breast NeoplasmsUltrasonic TherapyAntineoplastic AgentsHumansAnimalsMiceFemaleCell Line, TumorBenzamidesIndolesDioxoles

Stichwörter der Autor:innen

TGF-β inhibitorbiomimetic nanoparticlesimmune checkpoint blockadesonodynamic therapytumor microenvironment

Substanzen

Transforming Growth Factor beta4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideBenzamidesIndolesAntineoplastic AgentsDioxoles

Autor:innen und Institutionen

  • Department of Ultrasound, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Research Center of Ultrasonography, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Clinical Research Center for Ultrasound Diagnosis and Treatment in Hunan Province, Changsha 410011, China.
  • Department of Neurosurgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Hunan Engineering Research Center of Biomedical Metal and Ceramic Implants, Xiangya Hospital, Central South University, Changsha 410008, China.

ORCID-Profile: Long Wang, Chengcheng Niu

Förderung

  • Natural Science Foundation of Hunan Province
  • Science and Technology Program of Hunan Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Provincial Health Commission

Zitieren

APA

Liao, Z., Liao, H., Luo, Y., Chen, S., Chen, M., He, J., Xu, Y., Wang, L., & Niu, C. (2025). Red Blood Cell Membrane-Camouflaged Nanoparticles for Synergistic Sonodynamic Therapy and TGF-β Inhibition to Reprogram Immunosuppressive Tumor Microenvironment. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c07008

Vancouver

Liao Z, Liao H, Luo Y, Chen S, Chen M, He J, et al. Red Blood Cell Membrane-Camouflaged Nanoparticles for Synergistic Sonodynamic Therapy and TGF-β Inhibition to Reprogram Immunosuppressive Tumor Microenvironment. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c07008

BibTeX
@article{Liao2025,
  author = {Liao, Zhipeng and Liao, Haiqin and Luo, Yi and Chen, Sijie and Chen, Mingyu and He, Jiarong and Xu, Yan and Wang, Long and Niu, Chengcheng},
  title = {Red Blood Cell Membrane-Camouflaged Nanoparticles for Synergistic Sonodynamic Therapy and TGF-β Inhibition to Reprogram Immunosuppressive Tumor Microenvironment},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c07008}
}
Kostenlos starten →